Literature DB >> 18368381

Transcription factor FBI-1 acts as a dual regulator in adipogenesis by coordinated regulation of cyclin-A and E2F-4.

Matthias Laudes1, Roman Bilkovski, Frank Oberhauser, Andrea Droste, Matthias Gomolka, Uschi Leeser, Michael Udelhoven, Wilhelm Krone.   

Abstract

Generation of new adipocytes plays a major role in the development of obesity. We previously have shown that transcriptional repressor factor that binds to IST (FBI)-1 exerts a dual effect in the process of adipogenesis by inhibiting proliferation and promoting differentiation of preadipocytes. The aim of the present study was to identify FBI-1 regulated molecular effectors that could account for these effects. Overexpressing FBI-1 in preadipocytes resulted in reduced expression of the cell cycle regulator cyclin A, which may explain FBI-1 induced inhibition of proliferation. Interestingly, FBI-1 repressed cyclin A promoter activity through an indirect mechanisms that did not involve direct binding of FBI-1 to the promoter sequence, but rather FBI-1 inhibition of transcriptional activator Sp1 binding to a regulatory element at -452 to -443. We also show that FBI-1 promotes terminal preadipocyte differentiation through a mechanism involving decreased levels of expression of the PPARgamma inhibitor E2F-4. FBI-1 significantly reduced E2F-4 promoter activity. Contrary to cyclin A, we found FBI-1-induced repression of E2F-4 is mediated by a direct mechanism via a FBI-1 regulatory element at -11 to -5. As function of transcriptional repressors normally depends on the presence of regulatory co-factors we also performed expression profiling of potential FBI-1 co-repressors throughout adipogenesis. In these experiments Sin3A and histon deacetylase (HDAC)-1 showed a similar expression pattern compared to FBI-1. Strikingly, co-immunoprecipitation studies revealed that FBI-1 binds Sin3A and HDAC-1 to form a repressor complex. Furthermore, by mutational analysis the amino terminal Poxvirus (POZ) domain of FBI-1 was found to be important for Sin3A and HDAC-1 binding. Taken together, FBI-1 is the first transcriptional repressor shown to act as a dual regulator in adipogenesis exerting repressor activities on target genes by both, direct and indirect mechanisms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18368381     DOI: 10.1007/s00109-008-0326-2

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   5.606


  32 in total

Review 1.  Review: chromatin structural features and targets that regulate transcription.

Authors:  A P Wolffe; D Guschin
Journal:  J Struct Biol       Date:  2000-04       Impact factor: 2.867

2.  Flexible DNA binding of the BTB/POZ-domain protein FBI-1.

Authors:  Frank Pessler; Nouria Hernandez
Journal:  J Biol Chem       Date:  2003-05-15       Impact factor: 5.157

3.  SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia.

Authors:  S H Hong; G David; C W Wong; A Dejean; M L Privalsky
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

4.  Down-regulation of histone deacetylases stimulates adipocyte differentiation.

Authors:  Eung Jae Yoo; Jun-Jae Chung; Sung Sik Choe; Kang Ho Kim; Jae Bum Kim
Journal:  J Biol Chem       Date:  2006-01-05       Impact factor: 5.157

5.  Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene.

Authors:  J M Davies; N Hawe; J Kabarowski; Q H Huang; J Zhu; N J Brand; D Leprince; P Dhordain; M Cook; G Morriss-Kay; A Zelent
Journal:  Oncogene       Date:  1999-01-14       Impact factor: 9.867

6.  POZ domain transcription factor, FBI-1, represses transcription of ADH5/FDH by interacting with the zinc finger and interfering with DNA binding activity of Sp1.

Authors:  Dong-Kee Lee; Dongchul Suh; Howard J Edenberg; Man-Wook Hur
Journal:  J Biol Chem       Date:  2002-05-09       Impact factor: 5.157

7.  Crystal structure of the BTB domain from the LRF/ZBTB7 transcriptional regulator.

Authors:  Peter J Stogios; Lu Chen; Gilbert G Privé
Journal:  Protein Sci       Date:  2006-12-22       Impact factor: 6.725

8.  Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A.

Authors:  P L Yeyati; R Shaknovich; S Boterashvili; J Li; H J Ball; S Waxman; K Nason-Burchenal; E Dmitrovsky; A Zelent; J D Licht
Journal:  Oncogene       Date:  1999-01-28       Impact factor: 9.867

9.  Leukemia/lymphoma-related factor, a POZ domain-containing transcriptional repressor, interacts with histone deacetylase-1 and inhibits cartilage oligomeric matrix protein gene expression and chondrogenesis.

Authors:  Chuan-ju Liu; Lisa Prazak; Marc Fajardo; Shuang Yu; Neetu Tyagi; Paul E Di Cesare
Journal:  J Biol Chem       Date:  2004-08-26       Impact factor: 5.157

10.  CCAAT/enhancer-binding protein beta is required for mitotic clonal expansion during adipogenesis.

Authors:  Qi-Qun Tang; Tamara C Otto; M Daniel Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-13       Impact factor: 11.205

View more
  15 in total

1.  Expression of leukemia/lymphoma-related factor (LRF/POKEMON) in human breast carcinoma and other cancers.

Authors:  Anshu Aggarwal; William J Hunter; Himanshu Aggarwal; Edibaldo D Silva; Mary S Davey; Richard F Murphy; Devendra K Agrawal
Journal:  Exp Mol Pathol       Date:  2010-05-21       Impact factor: 3.362

2.  ZBTB7A governs estrogen receptor alpha expression in breast cancer.

Authors:  Mary Ellen Molloy; Monika Lewinska; Amanda K Williamson; Thanh Thao Nguyen; Gamze Kuser-Abali; Lu Gong; Jiawei Yan; John B Little; Pier Paolo Pandolfi; Zhi-Min Yuan
Journal:  J Mol Cell Biol       Date:  2018-08-01       Impact factor: 6.216

3.  The BTB-ZF family of transcription factors: key regulators of lineage commitment and effector function development in the immune system.

Authors:  Aimee M Beaulieu; Derek B Sant'Angelo
Journal:  J Immunol       Date:  2011-09-15       Impact factor: 5.422

4.  P-Glycoprotein/MDR1 regulates pokemon gene transcription through p53 expression in human breast cancer cells.

Authors:  Shengnan He; Feng Liu; Zhenhua Xie; Xuyu Zu; Wei Xu; Yuyang Jiang
Journal:  Int J Mol Sci       Date:  2010-08-27       Impact factor: 5.923

Review 5.  Role of LRF/Pokemon in lineage fate decisions.

Authors:  Andrea Lunardi; Jlenia Guarnerio; Guocan Wang; Takahiro Maeda; Pier Paolo Pandolfi
Journal:  Blood       Date:  2013-02-08       Impact factor: 22.113

6.  Proto-oncogene FBI-1 represses transcription of p21CIP1 by inhibition of transcription activation by p53 and Sp1.

Authors:  Won-Il Choi; Bu-Nam Jeon; Chae-Ok Yun; Pyung-Hwan Kim; Sung-Eun Kim; Kang-Yell Choi; Se Hoon Kim; Man-Wook Hur
Journal:  J Biol Chem       Date:  2009-02-25       Impact factor: 5.157

7.  Role of WNT-5a in the determination of human mesenchymal stem cells into preadipocytes.

Authors:  Roman Bilkovski; Dominik M Schulte; Frank Oberhauser; Matthias Gomolka; Michael Udelhoven; Moritz M Hettich; Bernhard Roth; Axel Heidenreich; Christian Gutschow; Wilhelm Krone; Matthias Laudes
Journal:  J Biol Chem       Date:  2009-12-23       Impact factor: 5.157

8.  Expression QTL modules as functional components underlying higher-order phenotypes.

Authors:  Lei Bao; Xuefeng Xia; Yan Cui
Journal:  PLoS One       Date:  2010-12-13       Impact factor: 3.240

9.  SP1 enhances Zbtb7A gene expression via direct binding to GC box in HePG2 cells.

Authors:  Xuyu Zu; Lingling Yu; Qinsheng Sun; Feng Liu; Jue Wang; Zhenhua Xie; Ying Wang; Wei Xu; Yuyang Jiang
Journal:  BMC Res Notes       Date:  2009-09-02

10.  The transcription factor FBI-1 inhibits SAM68-mediated BCL-X alternative splicing and apoptosis.

Authors:  Pamela Bielli; Roberta Busà; Savino M Di Stasi; Manuel J Munoz; Flavia Botti; Alberto R Kornblihtt; Claudio Sette
Journal:  EMBO Rep       Date:  2014-02-10       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.